Leap Therapeutics (NASDAQ: LPTX)
$0.37
(-2.2%)
-$0.01
Price as of April 16, 2025, 10:42 a.m. ET
LPTX
Key Data Points
Current Price
$0.37
Daily Change
(-2.2%) -$0.01
Day's Range
$0.36 - $0.37
Previous Close
$0.37
Open
$0.36
Beta
1.08
Volume
85,369
Average Volume
2,602,689
Sector
Market Cap
$15M
Market Cap / Employee
$297MM
52wk Range
$0.22 - $4.79
Revenue
-
Gross Margin
0%
Dividend Yield
N/A
EPS
-$1.84
CAPs Rating
-
Industry
Biotechnology
The Motley Fool Investing Philosophy: We generally recommend investors buy shares of at least 25 stocks and hold them for at least 5 years. Learn More
Leap Therapeutics Return vs. S&P
1 Year | 5 Year | 5 Year Annualized | Since IPO |
---|
Leap Therapeutics Company Info
Leap Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in developing novel therapies designed to treat patients with cancer. The company was founded on January 3, 2011 and is headquartered in Cambridge, MA.
News & Analysis
Featured Article
Why Leap Therapeutics Stock Is Surging Today
Positive clinical trial results are giving investors a reason to cheer.
Cory Renauer | Jan 19, 2022
Featured Article
2 Risky Growth Stocks That Could Make You Filthy Rich
These two biotech stocks are set to report key clinical data later this year.
George Budwell | Jan 16, 2022
Financial Health
General
Q4 2024 | YoY Change |
---|
Revenue Growth Rate
Earnings Per Share Growth Rate
Assets
Q4 2024 | YoY Change |
---|
Liabilities
Q4 2024 | YoY Change |
---|
Ratios
Q4 2024 | YoY Change |
---|
Cash Flow
Q4 2024 | YoY Change |
---|
Valuation
Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | YoY Change |
---|
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.